Ayurvedic management of Type 2 Dieabetes.

Etiopathological study of Type 2 Diabetes mellitus w.s.r. to Sthula Pramehi and its management with Asanadi Ghanavati- An Open Labelled Single Arm Clinical Trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021428

Enrollment

Registered

2019-09-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Asanadi GhanaVati: 4 Tab three times after meal a day. Intervention2: Asanadi Ghanvati: 4 tab of 500mg TDS Intervention3: Asanadi Ghanvati: 4 tab 500mg each tds 3month duration Control

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 30 years to 60 years. 2.For newly diagnosed Patients FBS >= 126 mg/dl and PP2BS >= 200 mg and above. 3.For known case of DM Type2 (FBS/PP2BS >= 140 any of type) upper limit for Blood sugar 4.BMI >25 Kg/m2 5.Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Age less than 30 years and more than 60 years. 2.FBS/PP2BS > 300mg/dl (any). Patients receiving insulin, secondary DM,gestational DM, pregnant women, lactating mother. 3.BMI 4.Patients who do not wish to participate in the study 5.Patients with Diabetic complications

Design outcomes

Primary

Measure	Time frame
Relief in symptoms of Type 2 Diabetes w.s.r to sthula pramehiTimepoint: 90 days (3 months)	—

Secondary

Measure	Time frame
Improvement of associated symptoms of Type 2 Diabetes w.s.r. to sthula pramehiTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Darshna Pandya

IPGT AND RA

darshnapandya73@gmail.com9099011095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026